Aerie Pharmaceuticals to Present at Two Investor Conferences in September
IRVINE, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (Nasdaq:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of glaucoma and other diseases of the eye, today announced that company management will present at the following conferences in September. Rodman & Renshaw 19th Annual Global Investment Conference (sponsored by H.C. Wainwright & Co., LLC) Presentation Date: Tuesday, Se